Fulcrum and Slate Medicines Agree to $245 Million Merger
Fulcrum Therapeutics and Slate Medicines have agreed to combine in an all-stock merger that will create a company…
Trending
- Fulcrum and Slate Medicines Agree to $245 Million Merger
- LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases
- Sandoz and Henlius Expand Global Biosimilar Collaboration
- FDA Grants Fast Track Status to Spevatamig for Biliary Cancer
- EMA Validates Pfizer and Valneva Lyme Disease Vaccine Application
- FDA Approves Lantheus Tau PET Imaging Agent for Alzheimer’s
- Aurisco Passes FDA Inspection for Generic Oligonucleotide APIs
- Alfasigma to Acquire Nordic Pharma in Global Expansion
- Lilly Files Six Lawsuits Against Black-Market Retatrutide Sellers
- Ivonescimab Wins China Approval for First-Line Squamous NSCLC
Top Headlines
LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases
LEO Pharma has agreed to acquire worldwide rights to dersimelagon from Tanabe Pharma in a deal that could reach up…
Sandoz and Henlius Expand Global Biosimilar Collaboration
Sandoz and Shanghai Henlius Biotech have entered into a major collaboration to develop, manufacture and…
FDA Grants Fast Track Status to Spevatamig for Biliary Cancer
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Phanes Therapeutics’ spevatamig…
EMA Validates Pfizer and Valneva Lyme Disease Vaccine Application
The European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for Pfizer and…
FDA Approves Lantheus Tau PET Imaging Agent for Alzheimer’s
The U.S. Food and Drug Administration (FDA) has approved Lantheus Holdings’ TAUKLARIFY (florquinitau F 18…
Featured Event
Clinical Trials
Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial
AstraZeneca and Ionis Pharmaceuticals have announced that their Phase III CARDIO-TTRansform trial evaluating Wainua (eplontersen) in patients with…
Boehringer Advances Phase III Cancer Precision Medicine Trials
Boehringer Ingelheim has announced the launch of three Phase III clinical trials aimed at advancing precision oncology for patients with some of the…
uniQure Reports Early Promise for Epilepsy Gene Therapy
uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with…
Massive Bio, Optellum Partner to Advance Lung Cancer Trial Access
Massive Bio and Optellum have announced a strategic collaboration designed to connect early lung cancer detection with faster access to clinical…
Phase 3 Success Boosts Prospects for Iza-Bren
SystImmune and Bristol Myers Squibb have reported positive Phase 3 results for izalontamab brengitecan (iza-bren), an investigational bispecific…
GSK Drug Bepirovirsen Shows Promise in Redefining Chronic Hepatitis B Treatment
British pharmaceutical company GSK has reported encouraging late-stage clinical trial results for bepirovirsen, an investigational therapy for chronic…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Bristol Myers Squibb Expands AI Supercomputer for Drug Discovery
Bristol Myers Squibb (BMS) is significantly expanding its artificial intelligence capabilities with the deployment…
Excalipoint and DP Technology Partner on AI Antibody Discovery Platform
Excalipoint Therapeutics and DP Technology have announced a strategic collaboration to develop a new artificial…
Drug Research
Sentynl, Mereo Partner to Advance Oral AATD Lung Disease Therapy
Sentynl Therapeutics, a U.S.-based biopharmaceutical company and wholly owned subsidiary of Zydus Lifesciences, has…
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Novartis Targets Breast Cancer With Novel PI3Kα Inhibitor Deal
Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an…
FDA Proposes New Steps to Streamline Biosimilar Drug Development
The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the…
Manufacturing
Fujifilm and Taiho Partner on Next-Generation ADC Manufacturing
FUJIFILM Corporation and Taiho Pharmaceutical have formed a strategic partnership to advance manufacturing…
Cellares and SonomaBio Partner on Automated Treg Cell Therapy Manufacturing
Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of…
Cellares, TScan Partner on Automated TSC-101 Manufacturing
Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical…
Fujifilm Expands Stem Cell Manufacturing in Wisconsin
FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development…
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
UCB Selects Georgia for Major U.S. Biologics Manufacturing Hub
UCB has announced plans to establish a major new biologics manufacturing facility in Gwinnett County, Georgia,…
LGM Pharma Expands U.S. Manufacturing With $15M Investment
LGM Pharma has announced a $9 million expansion across its U.S. manufacturing network, marking the second phase of…
Terumo BCT, Taiwan Bio Partner on Treg Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio…
Diseases
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet
Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS,…
AstraZeneca and Revna Biosciences Expand Lung Cancer Treatment Access in Ghana
Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides…
